Non-profit website: free to use. No fees from patients, hospitals or doctors. Not an agency. · Free · Not an agencyAbout this site
Medical oncology · Sun Yat-sen University Cancer Center · Guangzhou

Dr. Ma Yuxiang马宇翔

Associate Chief Physician

Summary compiled from public information, updated 18 Nov 2026. It has not been checked against the hospital website yet. Confirm details with the hospital before you travel.

Dr. Ma Yuxiang

Professional overview

Associate Chief Physician Ma Yuxiang works in the Department of Medical Oncology at Sun Yat-sen University Cancer Center. Specializing in precision treatment and clinical research for lung cancer and nasopharyngeal carcinoma.

SpecialtyMedical oncology
Clinical titleAssociate Chief Physician
Academic rolesMaster's Supervisor
DepartmentDepartment of Medical Oncology
HospitalSun Yat-sen University Cancer Center
CityGuangzhou
Hospital roleDeputy Director, Phase I Clinical Trial Ward, Department of Clinical Research

Areas of focus

Lung cancer precision therapyFocuses on precise diagnosis of driver genes (e.g., EGFR, ALK, BRAF) and individualized treatment planning, including targeted therapy, immunotherapy, and cell therapies such as CAR-T and TCR-T.
Nasopharyngeal carcinoma precision therapySpecializes in comprehensive treatment across disease stages—initial, recurrent, and metastatic—with emphasis on matching patients to subsequent therapies and novel agents.
Anticancer drug clinical trialsLeads over 200 clinical trials of investigational anticancer drugs, including ADCs, bispecific antibodies, and cell therapies, for patients with resistant or advanced solid tumors.

Background

  • 2019Awarded First Prize of Guangdong Medical Science and Technology Award for standardized treatment of advanced nasopharyngeal carcinoma
  • 2020Awarded Huaxia Medical Science and Technology Award for standardized treatment of advanced nasopharyngeal carcinoma
  • 2021Awarded First Prize of China Anti-Cancer Association Science and Technology Award (No. K-2102-1-3)
  • 2022Awarded First Prize of Guangdong Provincial Science and Technology Award (Project No. J14-1-02-R07, 7th contributor)

Experience & recognition

  • Led over 200 clinical trials of anticancer drugs, more than half being Class I novel drugs or imported agents
  • Published over 60 first-author SCI papers, including 12 with impact factor >10
  • Served as Assistant Editor of Frontiers in Oncology
  • Received State Council Special Allowance
  • Awarded 'People's Good Doctor' Clinical-Scientific Innovation Young-Middle-Aged Expert (nasopharyngeal carcinoma field), 2024
  • Awarded 'TBM Youth Outstanding Paper' Grand Prize at 2025 CACA Tumor Biomarker Academic Conference

Professional roles

  • Youth Committee Member, Integrated Oncology Society, China Anti-Cancer Association (CACA)
  • Secretary, Guangdong Provincial Clinical Medical Association Special Committee on Precision Therapy and Clinical Research for Lung Cancer
  • Vice Chair, First Committee of Guangdong Provincial Health Information Network Association Society for Intelligent Tumor Research
  • Youth Committee Member, Chemotherapy Professional Committee, Guangdong Anti-Cancer Association
  • Committee Member, Palliative Care and Rehabilitation Professional Committee, Guangdong Anti-Cancer Association
  • Member, Molecular Diagnostics Professional Committee, Guangdong Anti-Cancer Association

Frequently asked questions

What does Dr. Ma Yuxiang specialize in?

Precision diagnosis and treatment of lung cancer and nasopharyngeal carcinoma, including driver gene testing, targeted therapy, immunotherapy, cell therapy, and clinical trials of novel agents such as ADCs and bispecific antibodies.

Which hospital and department is Dr. Ma Yuxiang in?

Department of Medical Oncology at Sun Yat-sen University Cancer Center

Sources

Dr. Ma Yuxiang has not reviewed this page.